184 related articles for article (PubMed ID: 20397048)
1. Association between cyclin D1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Dig Dis Sci; 2010 Dec; 55(12):3449-57. PubMed ID: 20397048
[TBL] [Abstract][Full Text] [Related]
2. CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer.
Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I
Anticancer Res; 2010 Jan; 30(1):239-44. PubMed ID: 20150642
[TBL] [Abstract][Full Text] [Related]
3. Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa.
Takano H; Shibata T; Nakamura M; Sakurai N; Hayashi T; Ota M; Nomura-Horita T; Hayashi R; Shimasaki T; Otsuka T; Tahara T; Arisawa T
BMC Med Genet; 2020 Oct; 21(1):205. PubMed ID: 33066747
[TBL] [Abstract][Full Text] [Related]
4. Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Int J Mol Med; 2009 Oct; 24(4):563-9. PubMed ID: 19724898
[TBL] [Abstract][Full Text] [Related]
5. Association between IL-17A, -17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Int J Mol Med; 2010 Mar; 25(3):471-7. PubMed ID: 20127054
[TBL] [Abstract][Full Text] [Related]
6. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Digestion; 2010; 82(1):27-36. PubMed ID: 20150736
[TBL] [Abstract][Full Text] [Related]
7. Effect of polymorphisms of IL-1β and TNF-α genes on CpG island hyper methylation (CIHM) in the nonneoplastic gastric mucosa.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Hirata I; Arisawa T
Mol Carcinog; 2011 Nov; 50(11):835-45. PubMed ID: 21400614
[TBL] [Abstract][Full Text] [Related]
8. Chronic nonsteroidal anti-inflammatory drug (NSAID) use suppresses multiple CpG islands hyper methylation (CIHM) of tumor suppressor genes in the human gastric mucosa.
Tahara T; Shibata T; Yamashita H; Nakamura M; Yoshioka D; Okubo M; Hirata I; Arisawa T
Cancer Sci; 2009 Jul; 100(7):1192-7. PubMed ID: 19432886
[TBL] [Abstract][Full Text] [Related]
9. Association between polymorphisms in the XRCC1 and GST genes, and CpG island methylation status in colonic mucosa in ulcerative colitis.
Tahara T; Shibata T; Nakamura M; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Hirata I; Arisawa T
Virchows Arch; 2011 Feb; 458(2):205-11. PubMed ID: 21234761
[TBL] [Abstract][Full Text] [Related]
10. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk.
Kaise M; Yamasaki T; Yonezawa J; Miwa J; Ohta Y; Tajiri H
Helicobacter; 2008 Feb; 13(1):35-41. PubMed ID: 18205664
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of DNA repair and xenobiotic genes predispose to CpG island methylation in non-neoplastic gastric mucosa.
Tahara T; Shibata T; Nakamura M; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Ishizuka T; Hirata I; Arisawa T
Helicobacter; 2011 Apr; 16(2):99-106. PubMed ID: 21435086
[TBL] [Abstract][Full Text] [Related]
12. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
13. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
[TBL] [Abstract][Full Text] [Related]
14. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
[TBL] [Abstract][Full Text] [Related]
15. Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis.
Tahara T; Arisawa T; Shibata T; Nakamura M; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Takahama K; Watanabe M; Yamashita H; Hirata I
Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):613-9. PubMed ID: 19307977
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype.
Oue N; Oshimo Y; Nakayama H; Ito R; Yoshida K; Matsusaki K; Yasui W
Cancer Sci; 2003 Oct; 94(10):901-5. PubMed ID: 14556664
[TBL] [Abstract][Full Text] [Related]
17. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
18. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis.
Lu ZM; Zhou J; Wang X; Guan Z; Bai H; Liu ZJ; Su N; Pan K; Ji J; Deng D
PLoS One; 2012; 7(4):e35928. PubMed ID: 22558275
[TBL] [Abstract][Full Text] [Related]
19. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
[TBL] [Abstract][Full Text] [Related]
20. Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer.
Deng J; Liang H; Ying G; Zhang R; Wang B; Yu J; Fan D; Hao X
Oncotarget; 2014 May; 5(10):3173-83. PubMed ID: 24833402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]